New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in… EP News Bureau Apr 5, 2022 The treatment with Ocrevus resulted in a majority of patients experiencing no disease progression in a one-year analysis of…
Urgent need for disease-modifying drugs to arrest Parkinson’s disease progression: GlobalData EP News Bureau Apr 9, 2021 If any disease-modifying therapy managed to enter the PD market, it would revolutionise the treatment paradigm and generate a…
